Company intelligence / Profile preview

Ulysses Diversified Holdings

Hanover, New Hampshire, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Ulysses Diversified Holdings is active in founding, financing, and scaling innovative biotech and healthcare startups, with recent investment in Alloy Therapeutics' antibody platform at the Series C stage. No clinical results are attributed directly to Ulysses, but its portfolio includes clinical-stage companies.

Therapeutic areas: OncologyImmunology
Modalities: AntibodyMonoclonal antibody
Industry: Investors

Partnerships

8VCAlexandria Venture InvestmentsFounders FundGaingelsLuma Bio-ITMubadala CapitalPeter ThielPresight Capital

Beyond the preview

Go deeper on Ulysses Diversified Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ulysses Diversified Holdings.

Explore the full profile